help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vernooy, J. H.
Right arrow Articles by Wouters, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vernooy, J. H.
Right arrow Articles by Wouters, E. F.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1218-1224, (2002)
© 2002 American Thoracic Society

Original Article

Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

Soluble Tumor Necrosis Factor Receptors Are Increased in Sputum

Juanita H. Vernooy, Mehmet Küçükaycan, Jan A. Jacobs, Niels H. Chavannes, Wim A. Buurman, Mieke A. Dentener and Emiel F. Wouters

Nutrition and Toxicology Research Institute Maastricht, Departments of Pulmonology and General Surgery, Maastricht University; and Departments of Medical Microbiology and General Practice, University Hospital Maastricht, Maastricht, The Netherlands

Correspondence and requests for reprints should be addressed to Juanita H. J. Vernooy, M.Sc., Department of Pulmonology, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail: j.vernooy{at}pul.unimaas.nl

Chronic obstructive pulmonary disease (COPD) is characterized by significant chronic inflammation in the pulmonary compartment as well as in the circulation. This study aimed to elucidate the relationship between local and systemic inflammation in smoking-induced COPD by assessing levels of soluble (s) tumor necrosis factor (TNF) receptors, TNF-{alpha}, and interleukin-8 (IL-8) in induced sputum and in plasma. Sputum induction was performed in 18 subjects with COPD (FEV1 56% predicted) and 17 healthy smokers (FEV1 99% predicted). Patients with COPD showed significantly higher percentages of neutrophils and levels of sTNF-R55 and IL-8 in sputum as compared with control subjects, whereas sputum sTNF-R75 levels tended to be higher in COPD. Sputum TNF-{alpha} levels were similar in both groups. When comparing sTNF receptors in sputum and plasma, no direct correlations were found despite elevation of circulating sTNF-R75 levels in patients with COPD. In addition, sputum sTNF receptors were inversely related to the FEV1 in patients with COPD, whereas circulating sTNF receptors were not, suggesting different regulation of inflammation in the pulmonary and systemic compartment. When subjects were divided according to their current smoking status, levels of sTNF-R55, sTNF-R75, and IL-8 in sputum were significantly elevated in ex-smoking versus currently smoking patients with COPD, suggesting ongoing inflammation in airways and circulation of patients with COPD after smoking cessation.

Key Words: chronic obstructive pulmonary disease • pulmonary inflammation • systemic inflammation • smoking cessation • tumor necrosis factor receptors




This article has been cited by other articles:


Home page
 Therapeutic Advances in Respiratory DiseaseHome page
K. M. Kunisaki, K. L. Rice, E. N. Janoff, T. S. Rector, and D. E. Niewoehner
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 55 - 64.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J., February 1, 2008; 31(2): 416 - 469.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. H. Groenewegen, D. S. Postma, W. C. J. Hop, P. L. M. L. Wielders, N. J. J. Schlosser, E. F. M. Wouters, and for the COSMIC Study Group
Increased Systemic Inflammation Is a Risk Factor for COPD Exacerbations
Chest, February 1, 2008; 133(2): 350 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J., January 1, 2008; 31(1): 204 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)
Proceedings of the ATS, October 1, 2007; 4(7): 522 - 525.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
W. C. Bailey and D. P. Tashkin
Pharmacologic Therapy: Novel Approaches for Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, October 1, 2007; 4(7): 543 - 548.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi
Skeletal muscle adaptations to testosterone and resistance training in men with COPD
J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V. Pinto-Plata, J. Toso, K. Lee, D. Park, J. Bilello, H. Mullerova, M. M De Souza, R. Vessey, and B. Celli
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
Thorax, July 1, 2007; 62(7): 595 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen
Diaphragm Muscle Fiber Dysfunction in Chronic Obstructive Pulmonary Disease: Toward a Pathophysiological Concept
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1233 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Ma, Y. Y. Lin, and G. M. Turino
Measurements of Desmosine and Isodesmosine by Mass Spectrometry in COPD
Chest, May 1, 2007; 131(5): 1363 - 1371.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au
Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. H. Le Jemtel, M. Padeletti, and S. Jelic
Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 171 - 180.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
V. M. Pinto-Plata, G. Livnat, M. Girish, H. Cabral, P. Masdin, P. Linacre, R. Dew, L. Kenney, and B. R. Celli
Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD
Chest, January 1, 2007; 131(1): 37 - 43.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
J. H. J. Vernooy, R. H. E. Cloots, M. A. Dentener, and E. F. M. Wouters
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Eur. Respir. Rev., December 1, 2006; 15(101): 207 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. M. Henson, R. W. Vandivier, and I. S. Douglas
Cell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease?
Proceedings of the ATS, November 1, 2006; 3(8): 713 - 717.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. R. Bracke, A. I. D'hulst, T. Maes, K. B. Moerloose, I. K. Demedts, S. Lebecque, G. F. Joos, and G. G. Brusselle
Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema Are Attenuated in CCR6-Deficient Mice
J. Immunol., October 1, 2006; 177(7): 4350 - 4359.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
B. R. Celli
Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance
Proceedings of the ATS, August 1, 2006; 3(6): 461 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Agusti
Thomas A. Neff Lecture. Chronic Obstructive Pulmonary Disease: A Systemic Disease
Proceedings of the ATS, August 1, 2006; 3(6): 478 - 481.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Chaudhuri, E. Livingston, A. D. McMahon, J. Lafferty, I. Fraser, M. Spears, C. P. McSharry, and N. C. Thomson
Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma
Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 127 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. I. D'hulst, K. R. Bracke, T. Maes, J. L. De Bleecker, R. A. Pauwels, G. F. Joos, and G. G. Brusselle
Role of tumour necrosis factor-{alpha} receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema
Eur. Respir. J., July 1, 2006; 28(1): 102 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M A Dentener, R Louis, R H E Cloots, M Henket, and E F M Wouters
Differences in local versus systemic TNF{alpha} production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNF{alpha} release
Thorax, June 1, 2006; 61(6): 478 - 484.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. D. Pavord, S. S. Birring, M. Berry, R. H. Green, C. E. Brightling, and A. J. Wardlaw
Multiple inflammatory hits and the pathogenesis of severe airway disease.
Eur. Respir. J., May 1, 2006; 27(5): 884 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters
Approaches to Improving Health Status in Chronic Obstructive Pulmonary Disease: One or Several?
Proceedings of the ATS, May 1, 2006; 3(3): 262 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Gamble, Y. Qiu, D. Wang, J. Zhu, A. M. Vignola{dagger}, C. Kroegel, F. Morell, T. T. Hansel, I. D. Pavord, K. F. Rabe, et al.
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Eur. Respir. J., February 1, 2006; 27(2): 293 - 299.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Chakrabarti, J. M. Zee, and K. D. Patel
Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release
J. Leukoc. Biol., January 1, 2006; 79(1): 214 - 222.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. R. Hurst, W. R. Perera, T. M. A. Wilkinson, G. C. Donaldson, and J. A. Wedzicha
Systemic and Upper and Lower Airway Inflammation at Exacerbation of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 71 - 78.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Broekhuizen, E F M Wouters, E C Creutzberg, and A M W J Schols
Raised CRP levels mark metabolic and functional impairment in advanced COPD
Thorax, January 1, 2006; 61(1): 17 - 22.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V M Pinto-Plata, H Mullerova, J F Toso, M Feudjo-Tepie, J B Soriano, R S Vessey, and B R Celli
C-reactive protein in patients with COPD, control smokers and non-smokers
Thorax, January 1, 2006; 61(1): 23 - 28.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S Yende, G W Waterer, E A Tolley, A B Newman, D C Bauer, D R Taaffe, R Jensen, R Crapo, S Rubin, M Nevitt, et al.
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects
Thorax, January 1, 2006; 61(1): 10 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Wenten, K. Berhane, E. B. Rappaport, E. Avol, W.-W. Tsai, W. J. Gauderman, R. McConnell, L. Dubeau, and F. D. Gilliland
TNF-308 Modifies the Effect of Second-Hand Smoke on Respiratory Illness-related School Absences
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1563 - 1568.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. W. M. Willemse, N. H. T. ten Hacken, B. Rutgers, I. G. A. T. Lesman-Leegte, D. S. Postma, and W. Timens
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Eur. Respir. J., November 1, 2005; 26(5): 835 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. Takabatake, M. Sata, S. Inoue, Y. Shibata, S. Abe, T. Wada, J.-i. Machiya, G. Ji, T. Matsuura, Y. Takeishi, et al.
A Novel Polymorphism in Secretory Phospholipase A2-IID Is Associated with Body Weight Loss in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1097 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1105 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. C. Donaldson, T. A. R. Seemungal, I. S. Patel, A. Bhowmik, T. M. A. Wilkinson, J. R. Hurst, P. K. MacCallum, and J. A. Wedzicha
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Chest, October 1, 2005; 128(4): 1995 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. Wehlin, M. Lofdahl, J. Lundahl, and M. Skold
Reduced Intracellular Oxygen Radical Production in Whole Blood Leukocytes From COPD Patients and Asymptomatic Smokers
Chest, October 1, 2005; 128(4): 2051 - 2058.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
P. J. Barnes
New approaches to COPD
Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. van der Vaart, G. H. Koeter, D. S. Postma, H. F. Kauffman, and N. H. T. ten Hacken
First Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 465 - 469.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E-J D Oudijk, E H J Nijhuis, M D Zwank, E A van de Graaf, H J Mager, P J Coffer, J-W J Lammers, and L Koenderman
Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils
Thorax, July 1, 2005; 60(7): 538 - 544.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Yasuda, M. Yamaya, K. Nakayama, S. Ebihara, T. Sasaki, S. Okinaga, D. Inoue, M. Asada, M. Nemoto, and H. Sasaki
Increased Arterial Carboxyhemoglobin Concentrations in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1246 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. Buhl and S. G. Farmer
Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Parsons, M. A. Matthay, L. B. Ware, M. D. Eisner, and and the National Heart, Lung, Blood Institute Acut
Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L426 - L431.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M A Dentener, J H J Vernooy, S Hendriks, and E F M Wouters
Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation
Thorax, February 1, 2005; 60(2): 114 - 119.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Vassilakopoulos, C. Roussos, and S. Zakynthinos
The immune response to resistive breathing
Eur. Respir. J., December 1, 2004; 24(6): 1033 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. H. J. Vernooy, J. H. N. Lindeman, J. A. Jacobs, R. Hanemaaijer, and E. F. M. Wouters
Increased Activity of Matrix Metalloproteinase-8 and Matrix Metalloproteinase-9 in Induced Sputum From Patients With COPD
Chest, December 1, 2004; 126(6): 1802 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Vassilakopoulos, M. Divangahi, G. Rallis, O. Kishta, B. Petrof, A. Comtois, and S. N. A. Hussain
Differential Cytokine Gene Expression in the Diaphragm in Response to Strenuous Resistive Breathing
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 154 - 161.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
W Q Gan, S F P Man, A Senthilselvan, and D D Sin
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
Thorax, July 1, 2004; 59(7): 574 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Divangahi, S. Matecki, R. W. R. Dudley, S. A. Tuck, W. Bao, D. Radzioch, A. S. Comtois, and B. J. Petrof
Preferential Diaphragmatic Weakness during Sustained Pseudomonas aeruginosa Lung Infection
Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 679 - 686.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B.W.M. Willemse, D.S. Postma, W. Timens, and N.H.T. ten Hacken
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
Eur. Respir. J., March 1, 2004; 23(3): 464 - 476.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E-J.D. Oudijk, J-W.J. Lammers, and L. Koenderman
Systemic inflammation in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 5S - 13s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. Gamble, D. C. Grootendorst, C. E. Brightling, S. Troy, Y. Qiu, J. Zhu, D. Parker, D. Matin, S. Majumdar, A. M. Vignola, et al.
Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 976 - 982.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society